nach oben

Erschienen in:

2023 | OriginalPaper | Buchkapitel

6. Kardiale Erkrankungen

verfasst von : Brigitte Stiller

Erschienen in: Obladens Neugeborenenintensivmedizin

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Kritische angeborene strukturelle Herzfehler können duktusabhängig sein und sollten vom Neonatologen frühzeitig erkannt werden. Das Kapitel beschreibt diese Herzfehler in Symptomatik, Diagnostik und Therapie und beinhaltet anschauliche Zeichnungen der für die Neugeborenenperiode relevanten Herzfehler. Ferner werden Hyper- und Hypotonus ebenso wie die klinisch relevanten Herzrhythmusstörungen und die Intensivbehandlung der Herzinsuffizienz dargestellt.

Zu empfehlen sind die unter https://www.dgpk.org/leitlinien/ befindlichen aktuellen kostenfreien kinderkardiologischen Leitlinien der Fachgesellschaften.

Lindinger A, Schwedler G, Hense HW (2010) Prevalence of congenital heart defects in newborns in Germany: Results of the first registration year of the PAN Study (July 2006 to June 2007). Klin Padiatr 222(5):321–326PubMedCrossRef

Tanner K, Sabrine N, Wren C (2005) Cardiovascular malformations among preterm infants. Pediatrics 116(6):e833–e838PubMedCrossRef

Arlettaz R, Bauschatz AS, Mönkhoff M, Essers B, Bauersfeld U (2006) The contribution of pulse oximetry to the early detection of congenital heart disease in newborns. Eur J Pediatr 165(2):94–98PubMedCrossRef

Plana MN, Zamora J, Suresh G, Fernandez-Pineda L, Thangaratinam S, Ewer AK (2018) Pulse oximetry screening for critical congenital heart defects. Cochrane Datab Syst Rev 3(3):Cd011912

Groves AM, Singh Y, Dempsey E, Molnar Z, Austin T, El-Khuffash A et al (2018) Introduction to neonatologist-performed echocardiography. Pediatr Res 84(Suppl 1):1–12PubMedPubMedCentralCrossRef

Schubert S, Opgen-Rhein B, Boehne M, Weigelt A, Wagner R, Müller G et al (2019) Severe heart failure and the need for mechanical circulatory support and heart transplantation in pediatric patients with myocarditis: Results from the prospective multicenter registry „MYKKE“. Pediatr Transplant 23(7):e13548PubMedCrossRef

McCarthy RE 3rd, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM et al (2000) Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342(10):690–695PubMedCrossRef

Stiller B, Dähnert I, Weng YG, Hennig E, Hetzer R, Lange PE (1999) Children may survive severe myocarditis with prolonged use of biventricular assist devices. Heart 82(2):237–240PubMedPubMedCentralCrossRef

Robinson J, Hartling L, Vandermeer B, Sebastianski M, Klassen TP (2020) Intravenous immunoglobulin for presumed viral myocarditis in children and adults. Cochrane Datab Syst Rev 8(8):Cd004370

10.

Seidel F, Opgen-Rhein B, Rentzsch A, Boehne M, Wannenmacher B, Boecker D et al (2022) Clinical characteristics and outcome of biopsy-proven myocarditis in children – Results of the German prospective multicentre registry „MYKKE“. Int J Cardiol 357:95–104PubMedCrossRef

11.

Stiller B, Hetzer R, Weng Y, Hummel M, Hennig E, Nagdyman N et al (2003) Heart transplantation in children after mechanical circulatory support with pulsatile pneumatic assist device. J Heart Lung Transpl 22(11):1201–1208CrossRef

12.

Dodge-Khatami A, Ott S, Di Bernardo S, Berger F (2005) Carotid-subclavian artery index: new echocardiographic index to detect coarctation in neonates and infants. Ann Thorac Surg 80(5):1652–1657PubMedCrossRef

13.

Wood AE, Javadpour H, Duff D, Oslizlok P, Walsh K (2004) Is extended arch aortoplasty the operation of choice for infant aortic coarctation? Results of 15 years' experience in 181 patients. Ann Thorac Surg 77(4):1353–1357. discussion 7-8.PubMedCrossRef

14.

Shinkawa T, Bove EL, Hirsch JC, Devaney EJ, Ohye RG (2010) Intermediate-term results of the Ross procedure in neonates and infants. Ann Thorac Surg 89(6):1827–1832. discussion 32PubMedCrossRef

15.

Garty Y, Veldtman G, Lee K, Benson L (2005) Late outcomes after pulmonary valve balloon dilatation in neonates, infants and children. J Invas Cardiol 17(6):318–322

16.

Glen S, Burns J, Bloomfield P (2004) Prevalence and development of additional cardiac abnormalities in 1448 patients with congenital ventricular septal defects. Heart 90(11):1321–1325PubMedPubMedCentralCrossRef

17.

Wetter J, Belli E, Sinzobahamvya N, Blaschzok HC, Brecher AM, Urban AE (2001) Transposition of the great arteries associated with ventricular septal defect: surgical results and long-term outcome. Eur J Cardio-thoracic Surg 20(4):816–823CrossRef

18.

Tobler D, Williams WG, Jegatheeswaran A, Van Arsdell GS, McCrindle BW, Greutmann M et al (2010) Cardiac outcomes in young adult survivors of the arterial switch operation for transposition of the great arteries. J Am Coll Cardiol 56(1):58–64PubMedCrossRef

19.

Villafañe J, Feinstein JA, Jenkins KJ, Vincent RN, Walsh EP, Dubin AM et al (2013) Hot topics in tetralogy of Fallot. J Am Coll Cardiol 62(23):2155–2166PubMedCrossRef

20.

Paladini D, Pistorio A, Wu LH, Meccariello G, Lei T, Tuo G et al (2018) Prenatal diagnosis of total and partial anomalous pulmonary venous connection: multicenter cohort study and meta-analysis. Ultrasound Obstetric Gynecol 52(1):24–34CrossRef

21.

McDonald-McGinn DM, Sullivan KE, Marino B, Philip N, Swillen A, Vorstman JA et al (2015) 22q11.2 deletion syndrome. Nat Rev Dis Primers 1:15071PubMedPubMedCentralCrossRef

22.

Yerebakan C, Valeske K, Elmontaser H, Yörüker U, Mueller M, Thul J et al (2016) Hybrid therapy for hypoplastic left heart syndrome: Myth, alternative, or standard? J Thorac Cardiovasc Surg 151(4):1112–21, 23.e1-5CrossRef

23.

Alphonso N, Angelini A, Barron DJ, Bellsham-Revell H, Blom NA, Brown K et al (2020) Guidelines for the management of neonates and infants with hypoplastic left heart syndrome: The European Association for Cardio-Thoracic Surgery (EACTS) and the Association for European Paediatric and Congenital Cardiology (AEPC) Hypoplastic Left Heart Syndrome Guidelines Task Force. Eur J Cardio-thoracic Surg 58(3):416–499CrossRef

24.

ElHassan NO, Tang X, Gossett J, Zakaria D, Ross A, Kona SK et al (2018) Necrotizing enterocolitis in infants with hypoplastic left heart syndrome following stage 1 palliation or heart transplant. Pediatr Cardiol 39(4):774–785PubMedCrossRef

25.

McElhinney DB, Hedrick HL, Bush DM, Pereira GR, Stafford PW, Gaynor JW et al (2000) Necrotizing enterocolitis in neonates with congenital heart disease: risk factors and outcomes. Pediatrics 106(5):1080–1087PubMedCrossRef

26.

Ohye RG, Sleeper LA, Mahony L, Newburger JW, Pearson GD, Lu M et al (2010) Comparison of shunt types in the Norwood procedure for single-ventricle lesions. N Engl J Med 362(21):1980–1992PubMedPubMedCentralCrossRef

27.

Wernovsky G, Ghanayem N, Ohye RG, Bacha EA, Jacobs JP, Gaynor JW et al (2007) Hypoplastic left heart syndrome: consensus and controversies in 2007. Cardiol Young 17(Suppl 2):75–86PubMedCrossRef

28.

Photiadis J, Sinzobahamvya N, Hraška V, Asfour B (2012) Does bilateral pulmonary banding in comparison to Norwood procedure improve outcome in neonates with hypoplastic left heart syndrome beyond second-stage palliation? A review of the current literature. Thorac Cardiovasc Surg 60(3):181–188PubMedCrossRef

29.

Simons SH, van Dijk M, van Lingen RA, Roofthooft D, Boomsma F, van den Anker JN et al (2005) Randomised controlled trial evaluating effects of morphine on plasma adrenaline/noradrenaline concentrations in newborns. Arch Dis Child Fetal Neonatal Ed 90(1):F36–F40PubMedPubMedCentralCrossRef

30.

Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A et al (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341(10):709–717PubMedCrossRef

31.

Buck ML (2005) Clinical experience with spironolactone in pediatrics. Ann Pharmacother 39(5):823–828PubMedCrossRef

32.

Hoffman TM, Wernovsky G, Atz AM, Kulik TJ, Nelson DP, Chang AC et al (2003) Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 107(7):996–1002PubMedCrossRef

33.

Balaguru D, Auslender M (2000) Vasodilators in the treatment of pediatric heart failure. Prog Pediatr Cardiol 12(1):81–90PubMedCrossRef

34.

Hallik M, Ilmoja ML, Standing JF, Soeorg H, Jalas T, Raidmäe M et al (2020) Population pharmacokinetics and pharmacodynamics of dobutamine in neonates on the first days of life. Br J Clin Pharmacol 86(2):318–328PubMedPubMedCentralCrossRef

35.

Digitalis Investigation Group (1997) The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336(8):525–533CrossRef

36.

Alabed S, Sabouni A, Al Dakhoul S, Bdaiwi Y (2020) Beta-blockers for congestive heart failure in children. Cochrane Datab Syst Rev 7(7):Cd007037

37.

Initiative NN (1999) Systolic blood pressure in babies of less than 32 weeks gestation in the first year of life. Northern Neonatal Nursing Initiative. Arch Dis Child Fetal Neonatal Ed 80(1):F38–F42PubMedPubMedCentralCrossRef

38.

Osborn DA, Evans N (2004) Early volume expansion for prevention of morbidity and mortality in very preterm infants. Cochrane Datab Syst Rev 2004(2):Cd002055

39.

Brierley J, Carcillo JA, Choong K, Cornell T, Decaen A, Deymann A et al (2009) Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med 37(2):666–688PubMedPubMedCentralCrossRef

40.

Evans N, Kluckow M, Simmons M, Osborn D (2002) Which to measure, systemic or organ blood flow? Middle cerebral artery and superior vena cava flow in very preterm infants. Arch Dis Child Fetal Neonatal Ed 87(3):F181–F184PubMedPubMedCentralCrossRef

41.

Paradisis M, Osborn DA (2004) Adrenaline for prevention of morbidity and mortality in preterm infants with cardiovascular compromise. Cochrane Datab Syst Rev (1):Cd003958

42.

Pellicer A, Valverde E, Elorza MD, Madero R, Gayá F, Quero J et al (2005) Cardiovascular support for low birth weight infants and cerebral hemodynamics: a randomized, blinded, clinical trial. Pediatrics 115(6):1501–1512PubMedCrossRef

43.

Bhayat SI, Gowda HM, Eisenhut M (2016) Should dopamine be the first line inotrope in the treatment of neonatal hypotension? Review of the evidence. World J Clin Pediatr 5(2):212–222PubMedPubMedCentralCrossRef

44.

Subhedar NV, Shaw NJ (2003) Dopamine versus dobutamine for hypotensive preterm infants. Cochrane Datab Syst Rev 2003(3):Cd001242

45.

Adelman RD (1988) The hypertensive neonate. Clin Perinatol 15(3):567–585PubMedCrossRef

46.

Schwartz PJ, Garson A Jr, Paul T, Stramba-Badiale M, Vetter VL, Wren C (2002) Guidelines for the interpretation of the neonatal electrocardiogram. A task force of the European Society of Cardiology. Eur Heart J 23(17):1329–1344PubMedCrossRef

47.

Paul T, Bertram H, Kriebel T, Windhagen-Mahnert B, Tebbenjohanns J, Hausdorf G (2000) Supraventricular tachycardia in infants, children and adolescents: diagnosis, drug and interventional therapy. Z Kardiol 89(6):546–558PubMedCrossRef

48.

Paul T, Pfammatter JP (1997) Adenosine: an effective and safe antiarrhythmic drug in pediatrics. Pediatr Cardiol 18(2):118–126PubMedCrossRef

49.

Kriebel T, Lindinger A (2014) Tachycardiac arrhythmia in children without congenital heart diseases. Herzschrittmacherther Elektrophysiol 25(3):140–147PubMedCrossRef

50.

Deloof E, Devlieger H, Van Hoestenberghe R, Van den Berghe K, Daenen W, Gewillig M (1997) Management with a staged approach of the premature hydropic fetus due to complete congenital heart block. Eur J Pediatr 156(7):521–523PubMedCrossRef

51.

Dorostkar PC, Arko MK, Baird TM, Rodriguez S, Martin RJ (2005) Asystole and severe bradycardia in preterm infants. Biol Neonate 88(4):299–305PubMedCrossRef

52.

Akkinapally S, Hundalani SG, Kulkarni M, Fernandes CJ, Cabrera AG, Shivanna B et al (2018) Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions. Cochrane Datab Syst Rev 2(2):CD011417

53.

Vari D, Xiao W, Behere S, Spurrier E, Tsuda T, Baffa JM (2021) Low-dose prostaglandin E1 is safe and effective for critical congenital heart disease: is it time to revisit the dosing guidelines? Cardiol Young 31(1):63–70PubMedCrossRef

54.

Bauser-Heaton H, Qureshi AM, Goldstein BH, Glatz AC, Nicholson GT, Meadows JJ et al (2020) Use of carotid and axillary artery approach for stenting the patent ductus arteriosus in infants with ductal-dependent pulmonary blood flow: a multicenter study from the congenital catheterization research collaborative. Catheterization Cardiovasc Interv 95(4):726–733CrossRef

55.

Glatz AC, Petit CJ, Goldstein BH, Kelleman MS, McCracken CE, McDonnell A et al (2018) Comparison between patent ductus arteriosus stent and modified blalock-taussig shunt as palliation for infants with ductal-dependent pulmonary blood flow: insights from the congenital catheterization research collaborative. Circulation 137(6):589–601PubMedCrossRef

56.

Alsagheir A, Koziarz A, Makhdoum A, Contreras J, Alraddadi H, Abdalla T et al (2021) Duct stenting versus modified Blalock-Taussig shunt in neonates and infants with duct-dependent pulmonary blood flow: a systematic review and meta-analysis. J Thorac Cardiovasc Surg 161(2):379–90.e8PubMedCrossRef

57.

Kluckow M, Evans N (1995) Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr 127(5):774–779PubMedCrossRef

58.

Iyer P, Evans N (1994) Re-evaluation of the left atrial to aortic root ratio as a marker of patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 70(2):F112–F117PubMedPubMedCentralCrossRef

59.

Bell EF, Acarregui MJ (2014) Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Datab Syst Rev 2014(12):CD000503

60.

Runte KE, Flyer JN, Edwards EM, Soll RF, Horbar JD, Yeager SB. Variation of patent ductus arteriosus treatment in very low birth weight infants. Pediatrics 2021;148(5):e2021052874

61.

Evans P, O'Reilly D, Flyer JN, Soll R, Mitra S (2021) Indometacin for symptomatic patent ductus arteriosus in preterm infants. Cochrane Datab Syst Rev 1(1):CD013133

62.

Jansen EJS, Hundscheid T, Onland W, Kooi EMW, Andriessen P, de Boode WP (2021) Factors associated with benefit of treatment of patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. Front Pediatr 9:626262PubMedPubMedCentralCrossRef

63.

Umapathi KK, Muller B, Sosnowski C, Thavamani A, Murphy J, Awad S, et al. A novel patent ductus arteriosus severity score to predict clinical outcomes in premature neonates. J Cardiovasc Dev Dis 2022;9(4):114

64.

Ohlsson A, Walia R, Shah SS (2020) Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants. Cochrane Datab Syst Rev 2(2):CD003481

65.

Cooke L, Steer P, Woodgate P (2003) Indometacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Datab Syst Rev 2003(2):CD003745

66.

Herrera C, Holberton J, Davis P (2007) Prolonged versus short course of Indometacin for the treatment of patent ductus arteriosus in preterm infants. Cochrane Datab Syst Rev 2007(2):CD003480

67.

Malviya MN, Ohlsson A, Shah SS (2013) Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Datab Syst Rev 2013(3):CD003951

68.

Sathanandam SK, Gutfinger D, O'Brien L, Forbes TJ, Gillespie MJ, Berman DP et al (2020) Amplatzer Piccolo Occluder clinical trial for percutaneous closure of the patent ductus arteriosus in patients ≥700 grams. Catheterization Cardiovasc Interv 96(6):1266–1276CrossRef

69.

Pass RH, Hijazi Z, Hsu DT, Lewis V, Hellenbrand WE (2004) Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results. J Am Coll Cardiol 44(3):513–519PubMedCrossRef

70.

Shu LP, Zhang RH, Cai YH, Zhou JB, Yang JK, Qi L (2020) Maternal diabetes mellitus and persistent pulmonary hypertension of the newborn: accumulated evidence from observational studies. Can J Diabetes 44(4):327–34.e3PubMedCrossRef

71.

Zhou R, Zheng YN, Zhang XY, Cheng YY (2021) A meta-analysis of the risk factors of persistent pulmonary hypertension in newborns. Front Pediatr 9:659137PubMedPubMedCentralCrossRef

72.

Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL et al (2006) Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 354(6):579–587PubMedCrossRef

73.

Lin HC, Su BH, Lin TW, Tsai CH, Yeh TF (2005) System-based strategy for the management of meconium aspiration syndrome: 198 consecutive cases observations. Acta paediatrica Taiwanica = Taiwan er ke yi xue hui za zhi 46(2):67–71PubMed

74.

Lai MY, Chu SM, Lakshminrusimha S, Lin HC (2018) Beyond the inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Pediatric Neonatol 59(1):15–23CrossRef

75.

Wedgwood S, Black SM (2005) Endothelin-1 decreases endothelial NOS expression and activity through ETA receptor-mediated generation of hydrogen peroxide. Am J Physiol Lung Cell Mol Physiol 288(3):L480–L487PubMedCrossRef

76.

Michalsky MP, Arca MJ, Groenman F, Hammond S, Tibboel D, Caniano DA (2005) Alveolar capillary dysplasia: a logical approach to a fatal disease. J Pediatr Surg 40(7):1100–1105PubMedCrossRef

77.

Steinhorn RH, Cox PN, Fineman JR, Finer NN, Rosenberg EM, Silver MM et al (1997) Inhaled nitric oxide enhances oxygenation but not survival in infants with alveolar capillary dysplasia. J Pediatr 130(3):417–422PubMedCrossRef

78.

Reynolds EW, Ellington JG, Vranicar M, Bada HS (2004) Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn. Pediatrics 114(5):1297–1304PubMedCrossRef

79.

Finer NN, Barrington KJ (2006) Nitric oxide for respiratory failure in infants born at or near term. Cochrane Datab Syst Rev (4):CD000399

80.

Putnam LR, Tsao K, Morini F, Lally PA, Miller CC, Lally KP et al (2016) Evaluation of variability in inhaled nitric oxide use and pulmonary hypertension in patients with congenital diaphragmatic hernia. JAMA Pediatr 170(12):1188–1194PubMedCrossRef

81.

Barrington KJ, Finer N, Pennaforte T (2017) Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Datab Syst Rev 1(1):CD000509

82.

Howard LS, Morrell NW (2005) New therapeutic agents for pulmonary vascular disease. Paediatr Respir Rev 6(4):285–291PubMedCrossRef

83.

Kinsella JP, Truog WE, Walsh WF, Goldberg RN, Bancalari E, Mayock DE et al (1997) Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatr 131(1 Pt 1):55–62PubMedCrossRef

84.

Siefkes HM, Lakshminrusimha S (2021) Management of systemic hypotension in term infants with persistent pulmonary hypertension of the newborn: an illustrated review. Arch Dis Child Fetal Neonatal Ed 106(4):446–455PubMedCrossRef

85.

He Z, Zhu S, Zhou K, Jin Y, He L, Xu W et al (2021) Sildenafil for pulmonary hypertension in neonates: an updated systematic review and meta-analysis. Pediatr Pulmonol 56(8):2399–2412PubMedCrossRef

86.

Martinho S, Adão R, Leite-Moreira AF, Brás-Silva C (2020) Persistent pulmonary hypertension of the newborn: pathophysiological mechanisms and novel therapeutic approaches. Front Pediatr 8:342PubMedPubMedCentralCrossRef

87.

Shivanna B, Gowda S, Welty SE, Barrington KJ, Pammi M (2019) Prostanoids and their analogues for the treatment of pulmonary hypertension in neonates. Cochrane Datab Syst Rev 10(10):CD012963

88.

Mandell E, Kinsella JP, Abman SH (2021) Persistent pulmonary hypertension of the newborn. Pediatr Pulmonol 56(3):661–669PubMedCrossRef

89.

Barbaro RP, Bartlett RH, Chapman RL, Paden ML, Roberts LA, Gebremariam A et al (2016) Development and validation of the neonatal risk estimate score for children using extracorporeal respiratory support. J Pediatr 173:56 e3–61 e3CrossRef

90.

Mugford M, Elbourne D, Field D (2008) Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants. Cochrane Datab Syst Rev (3):CD001340

91.

Wild KT, Rintoul N, Kattan J, Gray B (2020) Extracorporeal life support organization (ELSO): guidelines for neonatal respiratory failure. ASAIO J 66(5):463–470PubMedCrossRef

92.

Wegele C, Schreiner Y, Perez Ortiz A, Hetjens S, Otto C, Boettcher M, et al. Impact of time point of extracorporeal membrane oxygenation on mortality and morbidity in congenital diaphragmatic hernia: a single-center case series. Children (Basel) 2022;9(7):986

93.

Hardart GE, Hardart MK, Arnold JH (2004) Intracranial hemorrhage in premature neonates treated with extracorporeal membrane oxygenation correlates with conceptional age. J Pediatr 145(2):184–189PubMedCrossRef

94.

Bahrami KR, Van Meurs KP (2005) ECMO for neonatal respiratory failure. Semin Perinatol 29(1):15–23PubMedCrossRef

95.

Perez Ortiz A, Glauner A, Dittgen F, Doniga T, Hetjens S, Schaible T et al (2022) Chronic lung disease following neonatal extracorporeal membrane oxygenation: a single-center experience. Front Pediatr 10:909862PubMedPubMedCentralCrossRef

Titel: Kardiale Erkrankungen
verfasst von: Brigitte Stiller
Verlag: Springer Berlin Heidelberg
Buch: Obladens Neugeborenenintensivmedizin
Print ISBN: 978-3-662-66571-8

Electronic ISBN: 978-3-662-66572-5

Copyright-Jahr: 2023
DOI: https://doi.org/10.1007/978-3-662-66572-5_6

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

6. Kardiale Erkrankungen

Zusammenfassung

Neu im Fachgebiet AINS

Akuter Schwindel: Wann lohnt sich eine MRT?

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Update AINS

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet AINS

Akuter Schwindel: Wann lohnt sich eine MRT?

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Update AINS